141 related articles for article (PubMed ID: 2463882)
21. Factor XII-independent activation of the bradykinin-forming cascade: Implications for the pathogenesis of hereditary angioedema types I and II.
Joseph K; Tholanikunnel BG; Bygum A; Ghebrehiwet B; Kaplan AP
J Allergy Clin Immunol; 2013 Aug; 132(2):470-5. PubMed ID: 23672780
[TBL] [Abstract][Full Text] [Related]
22. Dextran-induced lowering of prekallikrein proactivator and prekallikrein in rat plasma.
Briseid G; Briseid K; Toverud EL; Kristoffersen J
Acta Pharmacol Toxicol (Copenh); 1978 Feb; 42(2):93-102. PubMed ID: 580160
[TBL] [Abstract][Full Text] [Related]
23. Prekallikrein activation in the adult respiratory distress syndrome.
Schapira M; Gardaz JP; Py P; Lew PD; Perrin LH; Suter PM
Bull Eur Physiopathol Respir; 1985; 21(3):237-41. PubMed ID: 3873975
[TBL] [Abstract][Full Text] [Related]
24. Factor XII and prekallikrein-kallikrein-kinin in the cryoactivation of human plasma prorenin.
Brown CF; Osmond DH
Clin Sci (Lond); 1984 May; 66(5):533-9. PubMed ID: 6368100
[TBL] [Abstract][Full Text] [Related]
25. The kallikrein-kinin system in Bartter's syndrome and its response to prostaglandin synthetase inhibition.
Vinci JM; Gill JR; Bowden RE; Pisano JJ; Izzo JL; Radfar N; Taylor AA; Zusman RM; Bartter FC; Keiser HR
J Clin Invest; 1978 Jun; 61(6):1671-82. PubMed ID: 96139
[TBL] [Abstract][Full Text] [Related]
26. The plasma contact system in atopic asthma.
Lasser EC; Lang JH; Curd JG; Cochrane CG; Lyon SG; Howard MM; Hamblin AE; Revak SD
J Allergy Clin Immunol; 1983 Jul; 72(1):83-8. PubMed ID: 6189880
[TBL] [Abstract][Full Text] [Related]
27. Effect of surfaces on fluid-phase prekallikrein activation.
Scott CF; Kirby EP; Schick PK; Colman RW
Blood; 1981 Mar; 57(3):553-60. PubMed ID: 6906235
[TBL] [Abstract][Full Text] [Related]
28. Studies of the kallikrein-kinin system in patients with sickle cell anemia.
Miller RL; Verma PS; Adams RG
J Natl Med Assoc; 1983 Jun; 75(6):551-6. PubMed ID: 6603519
[TBL] [Abstract][Full Text] [Related]
29. A study of the plasma kinin-generating system in children with the minimal lesion, idiopathic nephrotic syndrome.
Kallen RJ; Lee SK
Pediatr Res; 1975 Sep; 9(9):705-9. PubMed ID: 53808
[TBL] [Abstract][Full Text] [Related]
30. Effects of cyclooxygenase inhibitors on plasma and urinary kallikrein.
Schor N; Voos A; Stella RC; Ribeiro AB; Ramos OL
Hypertension; 1983; 5(6 Pt 3):V48-52. PubMed ID: 6418649
[TBL] [Abstract][Full Text] [Related]
31. Naloxone attenuates the hypotension induced by Hageman factor.
Goldstein DJ; Pitterman AB; Frech M; Kelly G; Pisano JJ; Keiser HR
Life Sci; 1982 Jul; 31(4):341-5. PubMed ID: 6815399
[TBL] [Abstract][Full Text] [Related]
32. Kinin activation in the blood of patients with sepsis.
O'Donnell TF; Clowes GH; Talamo RC; Colman RW
Surg Gynecol Obstet; 1976 Oct; 143(4):539-45. PubMed ID: 959970
[TBL] [Abstract][Full Text] [Related]
33. A comparison of the effects of intravenous serotonin and dextran on the levels of factor XII, prekallikrein and plasminogen in rat plasma.
Berstad J
Acta Pharmacol Toxicol (Copenh); 1980 Apr; 46(4):314-20. PubMed ID: 6154406
[TBL] [Abstract][Full Text] [Related]
34. Prekallikrein activation and kallikrein inactivation in human plasma.
van der Graaf F; Keus JF; Koedam JA; Rietveld A; Bouma BN
Adv Exp Med Biol; 1983; 156():143-8. PubMed ID: 6190365
[No Abstract] [Full Text] [Related]
35. Recombinant alpha 1-antitrypsin Pittsburgh (Met 358----Arg) is a potent inhibitor of plasma kallikrein and activated factor XII fragment.
Schapira M; Ramus MA; Jallat S; Carvallo D; Courtney M
J Clin Invest; 1986 Feb; 77(2):635-7. PubMed ID: 3484756
[TBL] [Abstract][Full Text] [Related]
36. Changes in bradykinin and prostaglandins plasma levels during dextran-sulfate low-density-lipoprotein apheresis.
Kojima S; Ogi M; Yoshitomi Y; Kuramochi M; Ikeda J; Naganawa M; Hatakeyama H
Int J Artif Organs; 1997 Mar; 20(3):178-83. PubMed ID: 9151155
[TBL] [Abstract][Full Text] [Related]
37. A prealbumin activator of prekallikrein. 3. Appearance of chemotactic activity for human neutrophils by the conversion of human prekallikrein to kallikrein.
Kaplan AP; Kay AB; Austen KF
J Exp Med; 1972 Jan; 135(1):81-97. PubMed ID: 5009705
[TBL] [Abstract][Full Text] [Related]
38. Dextran sulfate-dependent fibrinolysis in whole human plasma.
Miles LA; Rothschild Z; Griffin JH
J Lab Clin Med; 1983 Feb; 101(2):214-25. PubMed ID: 6185600
[TBL] [Abstract][Full Text] [Related]
39. Evidence for the involvement of a plasma kallikrein-kinin system in the immediate hypotension produced by endotoxin in anaesthetized rats.
Katori M; Majima M; Odoi-Adome R; Sunahara N; Uchida Y
Br J Pharmacol; 1989 Dec; 98(4):1383-91. PubMed ID: 2692754
[TBL] [Abstract][Full Text] [Related]
40. Purification of guinea-pig plasma prekallikrein. Activation by prekallikrein activator derived from guinea-pig skin.
Yamamoto T; Kozono K; Okamoto T; Kato H; Kambara T
Biochim Biophys Acta; 1980 Aug; 614(2):511-25. PubMed ID: 6967737
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
